| 臺大學術典藏 |
2020-03-04T09:03:11Z |
Gender difference in statin intervention on blood lipid control among patients with coronary heart disease
|
Chen C.-Y.;Chuang S.-Y.;Fang C.-C.;Huang L.-C.;Hsieh I.-C.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Chen C.-Y.; Chuang S.-Y.; Fang C.-C.; Huang L.-C.; Hsieh I.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:10Z |
Gender disparities in optimal lipid control among patients with coronary artery disease
|
Chen C.-Y.;Chuang S.-Y.;Fang C.-C.;Huang L.-C.;Hsieh I.-C.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Chen C.-Y.; Chuang S.-Y.; Fang C.-C.; Huang L.-C.; Hsieh I.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:10Z |
Increased rosuvastatin dose versus concomitant fenofibrate and rosuvastatin therapy to achieve lipid goal in patients with diabetes or atherosclerosis with metabolic syndrome
|
Yin W.-H.; Chen J.-W.; Lee Y.-T.; CHAU-CHUNG WU; Tseng W.-K.; Chen Y.-P.;Chang K.-C.;Tseng W.-K.;Yin W.-H.;Chen J.-W.;Lee Y.-T.;Chau-Chung Wu; Chen Y.-P.; Chang K.-C. |
| 臺大學術典藏 |
2020-03-04T09:03:09Z |
The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan
|
Lin T.-H.;Chuang S.-Y.;Chu C.-Y.;Lee W.-H.;Hsu P.-C.;Su H.-M.;Li Y.-H.;Fang C.-C.;Wang K.-Y.;Tseng W.-K.;Li A.-H.;Ueng K.-C.;Hsieh I.-C.;Huang L.-C.;Wang C.-H.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Lin T.-H.; Chuang S.-Y.; Chu C.-Y.; Lee W.-H.; Hsu P.-C.; Su H.-M.; Li Y.-H.; Fang C.-C.; Wang K.-Y.; Tseng W.-K.; Li A.-H.; Ueng K.-C.; Hsieh I.-C.; Huang L.-C.; Wang C.-H.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:08Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Combination with low-dose dextromethorphan improves the effect of amlodipine monotherapy in clinical hypertension a first-in-human, concept-proven, prospective, dose-escalation, multicenter study
|
Yin W.-H.; Chen P.; Yeh H.-I.; Wang K.-Y.; Hung Y.-J.; Tseng W.-K.; Wen M.-S.; Wu T.-C.; CHAU-CHUNG WU; Cheng S.-M.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:04Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
Lin F.-J.;Tseng W.-K.;Yin W.-H.;Yeh H.-I.;Chen J.-W.;Chau-Chung Wu; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chou R.-H.;Huang C.-Y.;Huang P.-H.;Leu H.-B.;Yin W.-H.;Chau-Chung Wu;Lin S.-J.;Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; CHAU-CHUNG WU; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; Wu Y.-W.; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W.; Wu J.-R.;Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Wu J.-R. |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-03T02:28:40Z |
Magnolol: A multifunctional compound isolated from the Chinese medicinal plant Magnolia officinalis
|
Chen Y.-H. ;Huang P.-H. ;Lin F.-Y. ;Chen W.-C. ;Yuh-Lien Chen ;Yin W.-H. ;Man K.-M. ;Liu P.-L.; Chen Y.-H.; Huang P.-H.; Lin F.-Y.; Chen W.-C.; YUH-LIEN CHEN; Yin W.-H.; Man K.-M.; Liu P.-L. |
| 臺大學術典藏 |
2020-03-03T02:28:38Z |
Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization
|
Liu J.-T.; YUH-LIEN CHEN; Chen W.-C.; Chen H.-Y.; Lin Y.-W.; Wang S.-H.; Man K.-M.; Wan H.-M.; Yin W.-H.; Liu P.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2020-03-02T07:45:18Z |
Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization
|
Liu J.-T.;Chen Y.-L.;Chen W.-C.;Chen H.-Y.;Lin Y.-W.;Shu-Huei Wang;Man K.-M.;Wan H.-M.;Yin W.-H.;Liu P.-L.;Chen Y.-H.; Liu J.-T.; Chen Y.-L.; Chen W.-C.; Chen H.-Y.; Lin Y.-W.; SHU-HUEI WANG; Man K.-M.; Wan H.-M.; Yin W.-H.; Liu P.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2020-02-27T07:42:38Z |
2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
|
Chiang C.-E.; Wu T.-J.; Ueng K.-C.; Chao T.-F.; Chang K.-C.; Wang C.-C.; Lin Y.-J.; Yin W.-H.; Kuo J.-Y.; Lin W.-S.; Tsai C.-T.; Liu Y.-B.; Lee K.-T.; Lin L.-J.; Lin L.-Y.; Wang K.-L.; Chen Y.-J.; Chen M.-C.; Cheng C.-C.; Wen M.-S.; WEN-JONE CHEN; Chen J.-H.; Lai W.-T.; Chiou C.-W.; Lin J.-L.; Yeh S.-J.; Chen S.-A.; Chen S.-A.;Yeh S.-J.;Lin J.-L.;Chiou C.-W.;Lai W.-T.;Chen J.-H.;WEN-JONE CHEN;Wen M.-S.;Cheng C.-C.;Chen M.-C.;Chen Y.-J.;Wang K.-L.;Lin L.-Y.;Lin L.-J.;Lee K.-T.;Liu Y.-B.;Tsai C.-T.;Lin W.-S.;Kuo J.-Y.;Yin W.-H.;Lin Y.-J.;Wang C.-C.;Chang K.-C.;Chao T.-F.;Ueng K.-C.;Wu T.-J.;Chiang C.-E. |
| 臺大學術典藏 |
2020-02-25T09:38:31Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai, H.-S.;Tseng, W.-K.;Yin, W.-H.;Fang-Ju Lin;Hsuan, C.-F.;Wu, Y.-W.;Huang, L.-C.;Lin, T.-H.;Chang, K.-C.;Li, Y.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.; Tsai, H.-S.; Tseng, W.-K.; Yin, W.-H.; FANG-JU LIN; Hsuan, C.-F.; Wu, Y.-W.; Huang, L.-C.; Lin, T.-H.; Chang, K.-C.; Li, Y.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:24:04Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN; Yeh, H.-I.; Chen, J.-W.; Wu, Y.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:10:00Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
FANG-JU LIN; Tseng, W.-K.; Yin, W.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
